These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12483772)

  • 1. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.
    Van Steen K; Curran D; Kramer J; Molenberghs G; Van Vreckem A; Bottomley A; Sylvester R
    Stat Med; 2002 Dec; 21(24):3865-84. PubMed ID: 12483772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.
    Kramer JA; Curran D; Piccart M; de Haes JC; Bruning P; Klijn J; Van Hoorebeeck I; Paridaens R
    Eur J Cancer; 2000 Aug; 36(12):1498-506. PubMed ID: 10930797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.
    Efficace F; Biganzoli L; Piccart M; Coens C; Van Steen K; Cufer T; Coleman RE; Calvert HA; Gamucci T; Twelves C; Fargeot P; Bottomley A;
    Eur J Cancer; 2004 May; 40(7):1021-30. PubMed ID: 15093577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
    Park SH; Lee WK; Chung M; Bang SM; Cho EK; Lee JH; Shin DB
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):289-94. PubMed ID: 16010588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
    Carlson LE; Bultz BD; Morris DG
    Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles.
    Genre D; Protière C; Macquart-Moulin G; Gravis G; Camerlo J; Alzieu C; Maraninchi D; Moatti JP; Viens P
    Support Care Cancer; 2002 Apr; 10(3):222-30. PubMed ID: 11904787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of quality of life scores in patients with oesophageal cancer.
    Blazeby JM; Brookes ST; Alderson D
    Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
    Efficace F; Therasse P; Piccart MJ; Coens C; van Steen K; Welnicka-Jaskiewicz M; Cufer T; Dyczka J; Lichinitser M; Shepherd L; de Haes H; Sprangers MA; Bottomley A
    J Clin Oncol; 2004 Aug; 22(16):3381-8. PubMed ID: 15310784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
    Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
    J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients evaluate a quality of life scale: whose life is it anyway?
    Speca M; Robinson JW; Goodey E; Frizzell B
    Cancer Pract; 1994; 2(5):365-70. PubMed ID: 7697075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist.
    Kramer JA; Curran D; Piccart M; de Haes JC; Bruning PF; Klijn JG; Bontenbal M; van Pottelsberghe C; Groenvold M; Paridaens R
    Eur J Cancer; 2000 Aug; 36(12):1488-97. PubMed ID: 10930796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data.
    Bordeleau L; Szalai JP; Ennis M; Leszcz M; Speca M; Sela R; Doll R; Chochinov HM; Navarro M; Arnold A; Pritchard KI; Bezjak A; Llewellyn-Thomas HA; Sawka CA; Goodwin PJ
    J Clin Oncol; 2003 May; 21(10):1944-51. PubMed ID: 12743147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer.
    Parmar V; Badwe RA; Hawaldar R; Rayabhattanavar S; Varghese A; Sharma R; Mittra I
    Natl Med J India; 2005; 18(4):172-7. PubMed ID: 16252544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
    Efficace F; Bottomley A; Coens C; Van Steen K; Conroy T; Schöffski P; Schmoll H; Van Cutsem E; Köhne CH
    Eur J Cancer; 2006 Jan; 42(1):42-9. PubMed ID: 16298522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach.
    Koller M; Aaronson NK; Blazeby J; Bottomley A; Dewolf L; Fayers P; Johnson C; Ramage J; Scott N; West K;
    Eur J Cancer; 2007 Aug; 43(12):1810-20. PubMed ID: 17689070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.